A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma
Xinping Cao(Tianjin Medical University), Yifan Zhao(Tianjin Medical University), Mingfeng Zhao(Nankai University), Ruiting Guo(Tianjin Medical University), Shujing Guo(Tianjin Medical University), Rui Sun(Tianjin Medical University Eye Hospital), Mohan Zhao(Tianjin First Center Hospital), Jile Liu(Tianjin Medical University), Xiaomei Zhang(Tang Hospital)
Cited by 0
Related Papers
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
|Theranostics|2020|397
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149